# PROSTACOX : Metastatic Prostate Chemotherapy

> **NCT00213694** · — · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 52 (—)

## Conditions studied

- Metastatic Prostate Cancer

## Interventions

- **DRUG:** docetaxel and celecoxib

## Key facts

- **NCT ID:** NCT00213694
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 52 (—)
- **Last updated:** 2013-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213694, "PROSTACOX : Metastatic Prostate Chemotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00213694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*